CoChat

Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans

Open access
Farr, Joshua N, Rowsey, Jennifer L, Eckhardt, Brittany A, Thicke, Brianne S, Fraser, Daniel G, Tchkonia, Tamar, Kirkland, James L, Monroe, David G, Khosla, Sundeep · 2019 · Journal of Bone and Mineral Research
Cited by 122

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Estrogen deficiency is a seminal mechanism in the pathogenesis of osteoporosis. Mounting evidence, however, establishes that cellular senescence, a fundamental mechanism that drives multiple age-related diseases, also causes osteoporosis. Recently, we systematically identified an accumulation of senescent cells, characterized by increased p16Ink4a and p21Cip1 levels and development of a senescence-associated secretory phenotype (SASP), in mouse bone/marrow and human bone with aging. We then demonstrated that elimination of senescent cells prevented age-related bone loss using multiple approaches, eg, treating old mice expressing a “suicide” transgene, INK-ATTAC, with AP20187 to induce apoptosis of p16Ink4a-senescent cells or periodically treating old wild-type mice with “senolytics,” ie, drugs that eliminate senescent cells. Here, we investigate a possible role for estrogen in the regulation of cellular senescence using multiple approaches. First, sex steroid deficiency 2 months after ovariectomy (OVX, n = 15) or orchidectomy (ORCH, n = 15) versus sham surgery (SHAM, n = 15/sex) in young adult (4-month-old) wild-type mice did not alter senescence biomarkers or induce a SASP in bone. Next, in elderly postmenopausal women, 3 weeks of estrogen therapy (n = 10; 74 ± 5 years) compared with no treatment (n = 10; 78 ± 5 years) did not alter senescence biomarkers or the SASP in human bone biopsies. Finally, young adult (4-month-old) female INK-ATTAC mice were randomized (n = 17/group) to SHAM+Vehicle, OVX+Vehicle, or OVX+AP20187 for 2 months. As anticipated, OVX+Vehicle caused significant trabecular/cortical bone loss compared with SHAM+Vehicle. However, treatment with AP20187, which eliminates senescent cells in INK-ATTAC mice, did not rescue the OVX-induced bone loss or alter senescence biomarkers. Collectively, our data establish independent roles of estrogen deficiency and cellular senescence in the pathogenesis of osteoporosis, which has important implications for testing novel senolytics for skeletal efficacy, as these drugs will need to be evaluated in preclinical models of aging as opposed to the current FDA model of prevention of OVX-induced bone loss. © 2019 American Society for Bone and Mineral Research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.3729

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Khosla, 2018, Regulation of bone metabolism by sex steroids, Cold Spring Harb Perspect Med, 8, 1, 10.1101/cshperspect.a031211 · DOI · Paper page
  2. Almeida, 2017, Estrogens and androgens in skeletal physiology and pathophysiology, Physiol Rev., 97, 135, 10.1152/physrev.00033.2015 · DOI · Paper page
  3. Albright, 1940, Post-menopausal osteoporosis, Trans Assoc Am Physicians, 55, 298
  4. Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA., 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page
  5. Parente, 2008, Long-term impact of the women's health initiative on HRT, Arch Gynecol Obstet, 277, 219, 10.1007/s00404-007-0442-1 · DOI
  6. Khosla, 2010, Update on estrogens and the skeleton, J Clin Endocrinol Metab, 95, 3569, 10.1210/jc.2010-0856 · DOI · Paper page
  7. Farr, 2018, The spectrum of fundamental basic science discoveries contributing to organismal aging, J Bone Miner Res, 33, 1568, 10.1002/jbmr.3564 · DOI · Paper page
  8. Farr, 2016, Identification of senescent cells in the bone microenvironment, J Bone Miner Res, 31, 1920, 10.1002/jbmr.2892 · DOI · Paper page
  9. Piemontese, 2017, Old age causes de novo intracortical bone remodeling and porosity in mice, JCI Insight., 2, 1, 10.1172/jci.insight.93771 · DOI · Paper page
  10. Colman, 2003, The Food and Drug Administration's osteoporosis guidance document: past, present, and future, J Bone Miner Res, 18, 1125, 10.1359/jbmr.2003.18.6.1125 · DOI
  11. Rocca, 2016, Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study, Mayo Clin Proc, 91, 1577, 10.1016/j.mayocp.2016.08.002 · DOI · Paper page
  12. Rocca, 2017, Bilateral oophorectomy and accelerated aging: cause or effect?, J Gerontol A Biol Sci Med Sci, 72, 1213, 10.1093/gerona/glx026 · DOI · Paper page
  13. Rocca, 2018, Loss of ovarian hormones and accelerated somatic and mental aging, Physiology (Bethesda), 33, 374
  14. Fujita, 2014, Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women, J Clin Endocrinol Metab, 99, E81, 10.1210/jc.2013-3249 · DOI · Paper page
  15. Roforth, 2014, Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans, Bone., 59, 1, 10.1016/j.bone.2013.10.019 · DOI · Paper page
  16. Radonic, 2004, Guideline to reference gene selection for quantitative real-time PCR, Biochem Biophys Res Commun, 313, 856, 10.1016/j.bbrc.2003.11.177 · DOI · Paper page
  17. Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometeric averaging of multiple internal control genes, Genome Biol., 3, 10.1186/gb-2002-3-7-research0034 · DOI · Paper page
  18. Zhao, 2005, Comprehensive algorithm for quantitative real-time polymerase chain reaction, J Comput Biol, 12, 1047, 10.1089/cmb.2005.12.1047 · DOI · Paper page
  19. Fujita, 2014, Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture, Osteoporos Int., 25, 887, 10.1007/s00198-013-2529-9 · DOI · Paper page
  20. Efron, 2007, On testing the significance of sets of genes, Ann Appl Statist, 1, 107, 10.1214/07-AOAS101 · DOI · Paper page
  21. Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science., 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
  22. Jilka, 1992, Increased osteoclast development after estrogen loss: mediation by interleukin-6, Science., 257, 88, 10.1126/science.1621100 · DOI · Paper page
  23. Straub, 2007, The complex role of estrogens in inflammation, Endocr Rev., 28, 521, 10.1210/er.2007-0001 · DOI · Paper page

Cited by

See all 122

Metadata

Authors
Farr, J. N., Rowsey, J. L., Eckhardt, B. A., Thicke, B. S., Fraser, D. G., Tchkonia, T., Kirkland, J. L., Monroe, D. G., & Khosla, S.
Venue
Journal of Bone and Mineral Research
Published
2019-03-26
Volume
34
Issue
8
Pages
1407-1418
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2923907660
Cited by
122
References
30
FWCI
7.86
Type
journal article
Language
en
Open access
bronze
Funders
  • National Institute on Aging (AG013925, AG049182, AG048792, AG004875)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR068275, AR070241)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.